Compare · ICCM vs MDLN
ICCM vs MDLN
Side-by-side comparison of IceCure Medical Ltd. (ICCM) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICCM and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 4346.2x ICCM ($10.2M).
- Over the past year, ICCM is down 87.9% and MDLN is down 17.1% - MDLN leads by 70.8 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 6 for ICCM).
- MDLN has more recent analyst coverage (25 ratings vs 2 for ICCM).
PerformanceICCM-81.94%MDLN-17.07%
2025-12-17+0.00%2026-06-08
- Company
- IceCure Medical Ltd.
- Medline Inc.
- Price
- $3.69-15.17%
- $33.80+0.58%
- Market cap
- $10.2M
- $44.40B
- 1M return
- -50.92%
- -19.55%
- 1Y return
- -87.88%
- -17.07%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 6
- 20
- Recent ratings
- 2
- 25
ICCM
IceCure Medical Ltd.
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.
Latest ICCM
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
- SEC Form 6-K filed by IceCure Medical Ltd.
- SEC Form 4 filed by VP, R&D & Engineering Muchnik Naum
- New insider Peleg Meir claimed ownership of 400,000 units of Ordinary shares (SEC Form 3)
- SEC Form 4 filed by Chief Financial Officer Tsimerman Ronen
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
- SEC Form 424B5 filed by IceCure Medical Ltd.
- SEC Form 6-K filed by IceCure Medical Ltd.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)